FindTrial
Sign In

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02317263
Enrollment
0
Registered
2014-12-15
Start date
Unknown
Completion date
2099-01-31
Last updated
2016-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

MS

Brief summary

This is a multicenter, prospective, placebo-controlled, double-blind randomized Phase II clinical trial assessing the effect of testosterone treatment vs. placebo treatment for 96 weeks duration on whole brain atrophy in men with MS.

Interventions

DRUGtestosterone
DRUGplacebo gel

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Men, aged 18-60, with a diagnosis of multiple sclerosis by 2010 revised McDonald Criteria

Design outcomes

Primary

MeasureTime frame
Whole Brain Atrophy96 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026